Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future Research

Perinatal hypoxic-ischemic encephalopathy (HIE) remains a major cause of morbidity and mortality. Moderate hypothermia (33.5 °C) is currently the sole established standard treatment. However, there are a large number of infants for whom this therapy is ineffective. This inspired global research to f...

Descripción completa

Detalles Bibliográficos
Autores principales: Oorschot, Dorothy E., Sizemore, Rachel J., Amer, Ashraf R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073127/
https://www.ncbi.nlm.nih.gov/pubmed/32098276
http://dx.doi.org/10.3390/ijms21041487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073127/
https://www.ncbi.nlm.nih.gov/pubmed/32098276
http://dx.doi.org/10.3390/ijms21041487

Ejemplares similares